Home › Cases › NSTEMI Management in Chronic Kidney Disease

NSTEMI

NSTEMI Management in Chronic Kidney Disease

6 questions

Question 1 · AKI risk in NSTEMI

Mrs Begum, 71F, CKD stage 3b (eGFR 32). NSTEMI confirmed. How does CKD affect management?

Question 2 · Contrast-induced AKI prevention

Pre-angiography AKI prevention: a large contrast volume is anticipated and IV prophylaxis is planned. Which approach?

Question 3 · LMWH dosing in CKD

Mrs Begum has NSTEMI, stable renal function and calculated CrCl 32ml/min. No immediate angiography or high bleeding risk. Which anticoagulation approach?

Question 4 · DAPT in CKD

Dual antiplatelet therapy in CKD with NSTEMI?

Question 5 · Statins in CKD with NSTEMI

Mrs Begum's LDL 3.2. Statin intensity in CKD?

Question 6 · ACEi in CKD post-NSTEMI

LV function 40% post-NSTEMI; haemodynamically stable, eGFR 32 and K+ 4.5mmol/L. Start ACEi/ARB?

Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.

Ready for your next shift

Get it on your phone

Free, offline, no account.

Download bleep oncall

The current iPhone release, on the App Store.

Made between shifts

Keep bleep brewing.

Free to use. Ad-free by choice. If bleep has helped you through a shift, you can support what comes next.

Buy me a coffee

A small thank you. Always optional.